Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma

Prognostic tools are an essential component of the clinical management of patients with renal cell carcinoma (RCC). Although tumour stage and grade can provide important information, they fail to consider patient‐ and tumour‐specific biology. In this study, we set out to find a novel molecular marke...

Descripción completa

Detalles Bibliográficos
Autores principales: de Alwis, Roger, Schoch, Sarah, Islam, Mazharul, Möller, Christina, Ljungberg, Börje, Axelson, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240150/
https://www.ncbi.nlm.nih.gov/pubmed/36947439
http://dx.doi.org/10.1002/cjp2.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240150/
https://www.ncbi.nlm.nih.gov/pubmed/36947439
http://dx.doi.org/10.1002/cjp2.316

Ejemplares similares